Established in 2018, the company is young and ambitious. It specializes in the production, development and sales of single-use bronchoscopes in the field of medical device. Its core employees have more than 10 years' experience in materials, optics, structure, electronics, software, manufacturing and other fields.The company has already acquired CE and FDA certification, and has the capacity to high quality bronchoscopes. The company expands the sales overseas within 1 year, and now have acquired valued clients in Germany, Spain and the United State.
With the single-use endoscope, the efficiency of medical personnel will be improved. The main reason is that the single-use endoscope can be used after being disassembled and not requiring repeated cleaning like ordinary endoscope. Meanwhile, the most original samples from the patient's respiratory tract can be collected with the single-use endoscope if the patient is suspected with respiratory diseases. Above all, this single-use endoscope is sterile and can be discarded after the operation, thus substantially preventing cross infection of super drug-resistance bacteria.
This endoscope is distinguished from other similar products in the market. Its quality has been greatly improved. With the high-clearness images, the diagnosis of medical personnel is completed, and the risk of patients caused by quality problems is minimized with the help of the comprehensively upgraded material. This endoscope has a variety of technology and appearance patents. The disposable endoscope can be operated more conveniently and safely.
To develop the international market based on successful overseas sales experience, the company is looking to build long-term commercial agency agreements with EU and non-EU professional medical and pharmaceutical suppliers with documented records of working with health services, hospitals, and clinics. The product and after-sale service(including operating training service via video and instruction book etc. ) will be offered by the Chinese company after the commercial agency agreement signed.
The partners are targeted to the professional medical distribution companies already supplying medico / pharmaceuticals to hospitals and clinics.